公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker | Ho Y.-J.; Lin Y.-M.; Huang Y.-C.; Yeh K.-T.; LIANG-IN LIN ; Lu J.-W. | Acta Histochemica | 14 | 15 | |
2015 | TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution | HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo, Y.-Y.; Liu, C.-Y.; LIANG-IN LIN ; Tseng, M.-H.; Chiang, Y.-C.; Liu, M.-C.; Liu, C.-W.; JIH-LUH TANG ; MING YAO ; Li, C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood Cancer Journal | 112 | 111 | |
2014 | Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis | JIA-HUEI TSAI ; JAU-YU LIAU ; Lin Y.-L.; LIANG-IN LIN ; Cheng Y.-C.; Cheng M.-L.; YUNG-MING JENG | Modern Pathology | 62 | 58 | |
2016 | Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions | JIA-HUEI TSAI ; Cheng C.-H.; CHIEN-CHUAN CHEN ; Lin Y.-L.; LIANG-IN LIN ; Chen M.-L.; JAU-YU LIAU | Histopathology | 7 | 7 | |
2022 | Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis | Chang, Hui-Lan; KANG-YI SU ; Goodman, Steven D; WERN-CHERNG CHENG ; LIANG-IN LIN ; YA-CHIEN YANG ; SUI-YUAN CHANG ; WOEI-HORNG FANG | Journal of visualized experiments : JoVE | 1 | 1 | |
2023 | Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification | WAN-HSUAN LEE ; Tsai, Ming-Tao; Tsai, Cheng-Hong; FENG-MING TIEN ; Lo, Min-Yen; Tseng, Mei-Hsuan; Kuo, Yuan-Yeh; Liu, Ming-Chih; YI-TSUNG YANG ; JUI-CHE CHEN ; JIH-LUH TANG ; Sun, Hsun-I; Chuang, Yi-Kuang; LIANG-IN LIN ; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 1 | 0 | |
2023 | Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia | Lo, Min-Yen; Tsai, Xavier Cheng-Hong; CHIEN-CHIN LIN ; FENG-MING TIEN ; Kuo, Yuan-Yeh; WAN-HSUAN LEE ; Peng, Yen-Ling; Liu, Ming-Chih; Tseng, Mei-Hsuan; Hsu, Cheng-An; JUI-CHE CHEN ; LIANG-IN LIN ; Sun, Hsun-I; Chuang, Yi-Kuang; BOR-SHENG KO ; JIH-LUH TANG ; MING YAO ; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | American journal of hematology | 4 | 4 | |
2014 | Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivin | DA-LIANG OU ; Lee B.-S.; LIANG-IN LIN ; Liou J.-Y.; Liao S.-C.; CHIUN HSU ; ANN-LII CHENG | Molecular Cancer | 40 | 33 | |
2010 | WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system | HSIN-AN HOU ; TAI-CHUNG HUANG ; LIANG-IN LIN ; Liu C.-Y.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 142 | 137 | |
2015 | Zebrafish as a disease model for studying human hepatocellular carcinoma | Lu J.-W.; Ho Y.-J.; Yang Y.-J.; Liao H.-A.; Ciou S.-C.; LIANG-IN LIN ; DA-LIANG OU | World Journal of Gastroenterology | 49 | 38 | |
2015 | Zebrafish as a model for the study of human myeloid malignancies | Lu J.-W.; Hsieh M.-S.; Liao H.-A.; Yang Y.-J.; Ho Y.-J.; LIANG-IN LIN | BioMed Research International | 12 | 12 | |